Medicalgorithmics

Medicalgorithmics Financial Leverage

The Financial Leverage (Equity Multiplier) of Medicalgorithmics (MDG.WA) as of Oct 17, 2026 is 1.72. In the previous year, Financial Leverage (Equity Multiplier) was 1.37 — a change of 25.39% (higher).

Financial Leverage

1.72

YoY

25.39%

Last updated:

Financial Leverage (Equity Multiplier) of Medicalgorithmics is 2025 1.72 . Financial Leverage (Equity Multiplier) of Medicalgorithmics was 2024 1.37 . It decreases by 25.39% higher compared to the previous year.

The Medicalgorithmics Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.66 PLN
Jan 1, 2019
1.45 PLN
Jan 1, 2020
1.37 PLN
Jan 1, 2021
2.41 PLN
Jan 1, 2022
1.15 PLN
Jan 1, 2023
1.31 PLN
Jan 1, 2024
1.37 PLN
Jan 1, 2025
1.72 PLN
The Medicalgorithmics Financial Leverage history
YEARFinancial LeverageYoY
1.72+25.39%
1.37+4.34%
1.31+14.42%
1.15-52.43%
2.41+76.66%
1.37-5.51%
1.45-13.12%
1.66-2.79%
1.71-18.06%
2.09+102.72%
1.03-1.35%
1.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Medicalgorithmics Stock analysis

What does Medicalgorithmics do? Medicalgorithmics SA is a health care company based in Warsaw, Poland, with a focus on developing mobile electrocardiogram and arrhythmia diagnostic technology. The company has 122 employees and went public on November 9, 2011. Its primary product, PocketECG, enables remote monitoring of cardiac disorders and arrhythmia diagnosis, as well as monitoring of heart conditions and supporting clinical drug trials for cardiac safety. Medicalgorithmics SA also provides information technology and biotechnology services, along with conducting scientific research and development in the natural sciences. The company operates through subsidiaries including MEDICALGORITHMICS US HOLDING CORPORATION and Medi-Lynx Cardiac Monitoring LLC. It is listed on the Warsaw Stock Exchange under the ticker MDG.WA and has an ISIN of PLMDCLG00015. The company's activities include the development of tele-rehabilitation cardiology devices, software for optimizing hospital workflows, and systems for remote electrocardiography (ECG) description. Medicalgorithmics SA is engaged in the health care sector, specifically within the health care industry, serving both clinical and research applications in cardiology. Medicalgorithmics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medicalgorithmics stock

Financial Leverage (Equity Multiplier) of Medicalgorithmics is 1.72 in 2025.

Financial Leverage (Equity Multiplier) of Medicalgorithmics changed from 1.37 to 1.72, representing a 25.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Medicalgorithmics since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Medicalgorithmics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Medicalgorithmics

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Medicalgorithmics